Stockscreener 앱 받기
46.60
0.05%
0.1648
전일 마감가:
$46.44
열려 있는:
$46.5
하루 거래량:
24,977
Relative Volume:
0.02
시가총액:
$2.51B
수익:
$238.11M
순이익/손실:
$-31.45M
주가수익비율:
-73.58
EPS:
-0.6334
순현금흐름:
$7.66M
1주 성능:
-4.65%
1개월 성능:
+15.41%
6개월 성능:
+31.63%
1년 성능:
+193.34%
1일 변동 폭
$46.24
$46.83
1주일 범위
$45.26
$50.66
52주 변동 폭
$13.64
$50.66
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
46.61 | 2.63B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
114.56 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.92 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.21 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.51 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.43 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Wells Fargo | Overweight |
| 2025-12-01 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Lake Street | Buy |
| 2024-07-01 | 개시 | Raymond James | Outperform |
| 2022-11-11 | 재개 | Jefferies | Buy |
| 2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | Guggenheim | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 개시 | Canaccord Genuity | Buy |
| 2018-03-02 | 재확인 | Lake Street | Buy |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 개시 | Jefferies | Buy |
| 2017-11-21 | 재확인 | Lake Street | Buy |
| 2017-07-31 | 개시 | Leerink Partners | Outperform |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 개시 | ROTH Capital | Buy |
| 2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
| 2016-11-07 | 재확인 | Wedbush | Outperform |
| 2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
| 2016-08-04 | 재확인 | Wedbush | Outperform |
| 2014-05-14 | 개시 | Dawson James | Buy |
| 2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
Taxes of Axogen, Inc. – BMV:AXGN - TradingView
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Axogen, Inc. Cash Flow – BIVA:AXGN - TradingView
Axogen, Inc. Statistics – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen director Amy Wendell sells $646k in shares - Investing.com
Axogen director Amy Wendell sells $646k in shares By Investing.com - Investing.com Canada
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP - MarketBeat
Kathy Johnson Weiler Sells 14,150 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen, Inc. SEC Filing (Aug 11, 2026) - Stock Titan
Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed? - simplywall.st
Axogen Raises Its Revenue Outlook to at Least $279 Million But Does It Deserve An Upgrade? - Smartkarma
Axogen stock hits 52-week high at 47.09 USD By Investing.com - Investing.com South Africa
Axogen stock hits 52-week high at 47.09 USD - Investing.com India
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen, Inc. (AXGN) options chain - Yahoo Finance Australia
Assenagon Asset Management S.A. Trims Stock Position in AxoGen, Inc. $AXGN - MarketBeat
MFG Wealth Management Inc. Takes $1.20 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Axogen, Inc. (AXGN) director completes 14,150-share stock sale under Rule 10b5-1 plan - Stock Titan
AxoGen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Axogen (AXGN) Falls 2.28% as Shares Retreat Toward $42 Support ZoneLow Volume Node - Vinanet
HC Wainwright Forecasts AxoGen's Q3 Earnings (NASDAQ:AXGN) - MarketBeat
HC Wainwright Predicts AxoGen's Q1 Earnings (NASDAQ:AXGN) - MarketBeat
Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - Kalkine
Axogen Inc. (AXGN) Rises 2.08% to $42.21 as Nerve Repair Momentum BuildsAAII Neutral - Vinanet
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report - simplywall.st
Trace Biosciences Raises Strategic Investment From Axogen - Pulse 2.0
Vanguard Capital Management (AXGN) discloses 4.99% Axogen Inc ownership on Schedule 13G/A - Stock Titan
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55 - Moomoo
Citizens raises AxoGen stock price target to $55 on strong growth - Investing.com UK
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Incyte (INCY) - The Globe and Mail
H.C. Wainwright raises AxoGen stock price target to $53 on guidance - Investing.com Canada
AxoGen Inc (AXGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
0.75%
자본화:
|
볼륨(24시간):